S. Polyzos

发表

Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, European journal of gastroenterology & hepatology.

Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis

K. Toulis, S. Polyzos, P. Makras, 2011, Hormones.

Update on the association between non‐alcoholic fatty liver disease and Helicobacter pylori infection

A. Exadaktylos, A. Papaefthymiou, M. Doulberis, 2020, International journal of clinical practice.

Papillary thyroid microcarcinoma presenting as lymph node metastasis — a diagnostic challenge: case report and systematic review of literature

M. Alevizaki, S. Polyzos, P. Makras, 2012, Hormones.

A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration

E. Kazakos, M. Doulberis, J. Kountouras, 2018, Neurochemistry International.

Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis

E. Kazakos, E. Dardiotis, G. Xiromerisiou, 2017, Free radical research.

Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules

S. Polyzos, Z. Efstathiadou, A. Kourtis, 2008, Journal of Cancer Research and Clinical Oncology.

Thyroid nodules - stepwise diagnosis and management.

S. Polyzos, Stergios A Polyzos, A. Avramidis, 2007, Hormones.

Serum homocysteine, folate and vitamin B12 in patients with Paget’s disease of bone: the effect of zoledronic acid

S. Polyzos, E. Terpos, G. Arsos, 2010, Journal of Bone and Mineral Metabolism.

Serum Ferritin in Patients with Nonalcoholic Fatty Liver Disease: Evaluation of Ferritin to Adiponectin Ratio and Ferritin by Homeostatic Model of Assessment Insulin Resistance Product as Non-Invasive Markers

J. Kountouras, S. Polyzos, E. Terpos, 2012 .

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

D. Goulis, K. Toulis, J. Kountouras, 2011, Metabolism: clinical and experimental.

Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations.

S. Polyzos, M. Yavropoulou, P. Makras, 2021, Maturitas.

Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones

S. Polyzos, E. Armeni, K. Pafili, 2022, Journal of Endocrinological Investigation.

The therapeutic potential of C-C chemokine receptor antagonists in nonalcoholic steatohepatitis

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020 .

Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis.

C. Mantzoros, E. Kang, E. Rhee, 2020, Metabolism: clinical and experimental.

Emerging and future therapies for nonalcoholic steatohepatitis in adults

G. Mintziori, S. Polyzos, 2016, Expert opinion on pharmacotherapy.

Intracellular leptin signaling following effective weight loss.

C. Mantzoros, S. Polyzos, B. Schneider, 2015, Metabolism: clinical and experimental.

Nonalcoholic fatty liver disease: lifestyle and quality of life

S. Polyzos, P. Papaioannidou, A. Goulas, 2021, Hormones.

Irritable bowel syndrome associated with mitral valve prolapse and autonomic and haemostatic abnormalities in children, adolescents and adults with migraine

J. Kountouras, S. Polyzos, C. Zavos, 2011, Acta neurologica Scandinavica.

Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study

S. Polyzos, V. Athyros, A. Karagiannis, 2014, The open cardiovascular medicine journal.

Helicobacter pylori infection and esophageal adenocarcinoma: a review and a personal view

E. Kazakos, M. Doulberis, J. Kountouras, 2017, Annals of gastroenterology.

THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.

S. Polyzos, P. Makras, A. Anastasilakis, 2018, European journal of endocrinology.

Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms

C. Mantzoros, S. Polyzos, K. Pazaitou-Panayiotou, 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.

C. Mantzoros, S. Polyzos, 2016, Metabolism: clinical and experimental.

Molecular Links Between Alzheimer’s Disease and Gastrointestinal Microbiota: Emphasis on Helicobacter pylori Infection Involvement

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2021 .

Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways.

J. Kountouras, S. Polyzos, C. Zavos, 2009, Medical hypotheses.

Periostin on the road to nonalcoholic fatty liver disease

S. Polyzos, A. Anastasilakis, 2015, Endocrine.

Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2 diabetes mellitus patients inadequately treated with metformin monotherapy.

S. Polyzos, I. Zografou, N. Kartali, 2013, Advances in medical sciences.

Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study.

C. Mantzoros, J. Kountouras, S. Polyzos, 2019, Metabolism: clinical and experimental.

Coincidental thyroid papillary microcarcinoma in a patient treated for a toxic adenoma of the thyroid.

D. Goulis, S. Polyzos, 2011, Archives of Iranian medicine.

Alterations in serum thyroid-related constituents after thyroid fine-needle biopsy: a systematic review.

S. Polyzos, A. Anastasilakis, 2010, Thyroid : official journal of the American Thyroid Association.

Infectious thyroiditis as a complication of fine-needle biopsy: a systematic review

S. Polyzos, A. Anastasilakis, 2010, Expert review of endocrinology & metabolism.

Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man Hiperparatiroidismo primário e carcinoma papilífero metastático, multifocal e incidental da tiroide em paciente do sexo masculino

S. Polyzos, A. Anastasilakis, I. Iakovou, 2010 .

Polyautoimmunity in a Greek cohort of multiple sclerosis

J. Kountouras, S. Polyzos, C. Zavos, 2015, Acta neurologica Scandinavica.

Relationship between Helicobacter pylori infection and multiple sclerosis

J. Kountouras, S. Polyzos, D. Tsiptsios, 2015, Annals of gastroenterology.

A Systematic Review of Cases Reporting Needle Tract Seeding Following Thyroid Fine Needle Biopsy

S. Polyzos, A. Anastasilakis, 2010, World Journal of Surgery.

Rare potential complications of thyroid fine needle biopsy.

S. Polyzos, A. Anastasilakis, 2011, Hippokratia.

Systematic review of cases reporting blood extravasation-related complications after thyroid fine-needle biopsy.

S. Polyzos, A. Anastasilakis, 2010, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale.

Histological alterations following thyroid fine needle biopsy: A systematic review

S. Polyzos, K. Patsiaoura, Konstantia Zachou, 2009, Diagnostic cytopathology.

Letter: Helicobacter pylori‐related non‐alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia

E. Kazakos, E. Dardiotis, J. Kountouras, 2017, Alimentary pharmacology & therapeutics.

Eradication of Helicobacter pylori infection might have a positive impact on subpopulations with endoscopic gastro-oesophageal reflux disease.

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, European journal of gastroenterology & hepatology.

Impact of Helicobacter pylori Infection on Colon Oncogenesis

J. Kountouras, S. Polyzos, P. Katsinelos, 2013, American Journal of Gastroenterology.

Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.

S. Polyzos, P. Makras, A. Anastasilakis, 2013, The Journal of clinical endocrinology and metabolism.

Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment

S. Polyzos, E. Terpos, P. Makras, 2015, Expert opinion on therapeutic targets.

Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid

S. Polyzos, E. Terpos, A. Anastasilakis, 2009, Supportive Care in Cancer.

Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.

D. Goulis, S. Polyzos, A. Anastasilakis, 2008, Endocrine journal.

No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial

S. Polyzos, A. Anastasilakis, Z. Efstathiadou, 2009, Clinical endocrinology.

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

T. Rachner, L. Hofbauer, S. Polyzos, 2019, Osteologie.

Clinical Features of 24 Patients With Rebound‐Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases

S. Polyzos, P. Makras, A. Anastasilakis, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Denosumab versus zoledronic acid in patients previously treated with zoledronic acid

S. Polyzos, P. Makras, A. Anastasilakis, 2015, Osteoporosis International.

Combination and sequential treatment in women with postmenopausal osteoporosis

S. Polyzos, M. Yavropoulou, P. Makras, 2020, Expert opinion on pharmacotherapy.

Normochromic normocytic anemia in a postmenopausal woman with severe osteoporosis treated with intermittent parathyroid hormone

S. Polyzos, A. Anastasilakis, S. Delaroudis, 2010, Journal of Bone and Mineral Metabolism.

Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatide.

S. Polyzos, V. Pavlidou, A. Anastasilakis, 2008, European journal of endocrinology.

SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR.

C. Mantzoros, S. Polyzos, K. Pazaitou-Panayiotou, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease

J. Kountouras, S. Polyzos, C. Zavos, 2010, Diabetes, obesity & metabolism.

Investigating the role of Natural Killer T-cells in Gram negative infections of patients with type 2 diabetes mellitus.

S. Polyzos, A. Tsapas, K. Paletas, 2015, Hippokratia.

Continuous subcutaneous insulin infusion versus multiple daily injections.

S. Polyzos, S. Stergiopoulos, I. Zografou, 2009, Hippokratia.

Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity.

E. Papakonstantinou, J. Kountouras, S. Polyzos, 2020, Hepatobiliary surgery and nutrition.

Rodent models of obesity.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, Minerva endocrinologica.

Serum homocysteine levels in patients with nonalcoholic fatty liver disease.

J. Kountouras, S. Polyzos, P. Katsinelos, 2011, Annals of hepatology.

Sarcopenic obesity

S. Polyzos, A. Margioris, 2018, Hormones.

Helicobacter pylori infection and colorectal carcinoma: pathologic aspects.

J. Kountouras, S. Polyzos, P. Katsinelos, 2012, Journal of gastrointestinal oncology.

Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.

C. Mantzoros, S. Polyzos, N. Perakakis, 2019, Metabolism: clinical and experimental.

Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need

C. Mantzoros, S. Polyzos, 2022, Current medical research and opinion.

Irisin: a renaissance in metabolism?

C. Mantzoros, J. Kountouras, S. Polyzos, 2013, Metabolism: clinical and experimental.

Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis.

J. Kountouras, S. Polyzos, C. Zavos, 2010, Journal of clinical gastroenterology.

Nonalcoholic Fatty Liver Disease and Adipokines: A Novel Role for Fat Imbalance

S. Polyzos, 2013 .

Adiponectin in non‐alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas

J. Kountouras, S. Polyzos, C. Zavos, 2011, International journal of clinical practice.

Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis

J. Kountouras, S. Polyzos, C. Zavos, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Diabetes mellitus: 100 years since the discovery of insulin.

C. Mantzoros, S. Polyzos, 2021, Metabolism: clinical and experimental.

Nonalcoholic Fatty Liver Disease and Adipokines

J. Kountouras, S. Polyzos, C. Zavos, 2011 .

Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy.

C. Mantzoros, S. Polyzos, A. Anastasilakis, 2017, Metabolism: clinical and experimental.

Bone and fat interplay in inflammatory bowel disease: clinical implications and future perspectives.

J. Kountouras, S. Polyzos, 2014, Inflammatory bowel diseases.

Combination Therapies for Nonalcoholic Fatty Liver Disease

S. Polyzos, E. Makri, Eleftheria Makri, 2022, Journal of personalized medicine.

Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations

S. Polyzos, E. Tsochatzis, S. Kechagias, 2021, Alimentary pharmacology & therapeutics.

The role of cytokines and adipocytokines in zoledronate‐induced acute phase reaction in postmenopausal women with low bone mass

S. Polyzos, P. Makras, A. Anastasilakis, 2012, Clinical endocrinology.

Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.

J. Kountouras, S. Polyzos, P. Katsinelos, 2016, Annals of hepatology.

Leptin in nonalcoholic fatty liver disease: a narrative review.

C. Mantzoros, J. Kountouras, S. Polyzos, 2015, Metabolism: clinical and experimental.

Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis

Maria F. Vasiloglou, C. Mantzoros, K. Aronis, 2015, Diabetologia.

Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease

D. Goulis, S. Polyzos, O. Giouleme, 2022, Current Obesity Reports.

The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature.

J. Kountouras, S. Polyzos, C. Zavos, 2011, Journal of clinical gastroenterology.

Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.

L. Duntas, M. Doulberis, J. Kountouras, 2019, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.

C. Mantzoros, J. Kountouras, S. Polyzos, 2020, The Journal of clinical endocrinology and metabolism.

Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort

J. Kountouras, S. Polyzos, P. Katsinelos, 2018, Hormone and Metabolic Research.

Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment

M. Doulberis, J. Kountouras, S. Polyzos, 2018, Hormones.

Circulating periostin in patients with nonalcoholic fatty liver disease

J. Kountouras, S. Polyzos, E. Terpos, 2017, Endocrine.

Activin A and follistatin in patients with nonalcoholic fatty liver disease.

C. Mantzoros, J. Kountouras, S. Polyzos, 2016, Metabolism: clinical and experimental.

Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease

J. Kountouras, S. Polyzos, E. Terpos, 2016, Journal of Bone and Mineral Metabolism.

Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study.

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, Arquivos de gastroenterologia.

Irisin in patients with nonalcoholic fatty liver disease.

C. Mantzoros, J. Kountouras, S. Polyzos, 2014, Metabolism: clinical and experimental.

Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.

J. Kountouras, S. Polyzos, E. Terpos, 2013, Annals of hepatology.

Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease

A. Tsatsoulis, J. Kountouras, S. Polyzos, 2013, Hormones.

Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.

J. Kountouras, S. Polyzos, E. Terpos, 2013, Metabolism: clinical and experimental.

Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease

J. Kountouras, S. Polyzos, E. Katsiki, 2012, International journal of food sciences and nutrition.

Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease

J. Kountouras, S. Polyzos, E. Katsiki, 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Selenium and selenoprotein P in nonalcoholic fatty liver disease

L. Duntas, J. Kountouras, S. Polyzos, 2019, Hormones.

Adipose tissue, obesity and non-alcoholic fatty liver disease.

C. Mantzoros, J. Kountouras, S. Polyzos, 2017, Minerva endocrinologica.

Impact of Helicobacter pylori‐related metabolic syndrome with hyperhomocysteinemia on extragastric pathologies

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2021, Journal of gastroenterology and hepatology.

Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy

J. Kountouras, S. Polyzos, 2019, Helicobacter.

Helicobacter pylori Infection and Serum Adiponectin

J. Kountouras, S. Polyzos, C. Zavos, 2013, Helicobacter.

Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?

C. Mantzoros, S. Polyzos, E. Douni, 2019, Metabolism: clinical and experimental.

Irisin in metabolic diseases

C. Mantzoros, J. Kountouras, S. Polyzos, 2018, Endocrine.

Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.

Maria F. Vasiloglou, C. Mantzoros, S. Polyzos, 2014, The Journal of clinical endocrinology and metabolism.

An update on the validity of irisin assays and the link between irisin and hepatic metabolism.

C. Mantzoros, S. Polyzos, 2015, Metabolism: clinical and experimental.

Irisin: A true, circulating hormone.

C. Mantzoros, S. Polyzos, H. Mathew, 2015, Metabolism: clinical and experimental.

Associations of estrogen receptor alpha and Beta gene polymorphisms with lipid levels and insulin resistance in men.

S. Polyzos, A. Bargiota, Z. Efstathiadou, 2015, Metabolism: clinical and experimental.

Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease

I. Lambrinoudaki, D. Goulis, S. Polyzos, 2022, Hormones.

Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease.

C. Mantzoros, J. Kountouras, S. Polyzos, 2012, Metabolism: clinical and experimental.

Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.

J. Kountouras, S. Polyzos, C. Zavos, 2009, Current molecular medicine.

Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Expert opinion on pharmacotherapy.

Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis.

S. Polyzos, Z. Karabouta, V. Venetsanaki, 2019, European journal of pharmacology.

A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology.

J. Kountouras, S. Polyzos, P. Katsinelos, 2016, Journal of gastrointestinal and liver diseases : JGLD.

Helicobacter pylori-related ApoE 4 polymorphism may be associated with dysphagic symptoms in older adults.

M. Tsolaki, J. Kountouras, S. Polyzos, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus.

S. Polyzos, P. Papaioannidou, A. Goulas, 2020, Diabetes & metabolic syndrome.

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

C. Mantzoros, E. Cholongitas, C. Vlachopoulos, 2017, Metabolism: clinical and experimental.

Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Carcinogenesis.

Response to letter to the editor of Carcinogenesis by Li et al., 2020.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020 .

Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Carcinogenesis.

Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer

S. Polyzos, N. Katsiki, 2022, Hormones.

Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease

D. Goulis, S. Polyzos, O. Giouleme, 2022, Current Obesity Reports.

Long-term statin treatment for hepatic fibrosis in patients with nonalcoholic fatty liver disease: is it time to give the emperor a statin robe?

C. Mantzoros, S. Polyzos, V. Athyros, 2021, Metabolism: clinical and experimental.

Nonalcoholic fatty future disease.

C. Mantzoros, S. Polyzos, 2016, Metabolism: clinical and experimental.

Acromegaly: presentation, morbidity and treatment outcomes at a single centre

S. Polyzos, S. Katergari, Z. Efstathiadou, 2011, International journal of clinical practice.

Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates

C. Annweiler, D. Naughton, C. Wagner, 2017, Endocrine.

Vitamin D Deﬁciency and Unclear Abdominal Pain in Patients from Low- and Middle-Income Countries

A. Exadaktylos, A. Papaefthymiou, M. Doulberis, 2022 .

Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society.

E. McCloskey, M. Zillikens, S. Polyzos, 2019, Bone.

Obesity and the nervous system: more questions

M. Doulberis, J. Kountouras, S. Polyzos, 2017, The Lancet Neurology.

A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein

J. Kountouras, S. Polyzos, P. Katsinelos, 2012, Cancer Immunology, Immunotherapy.

Alzheimer’s disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, The International journal of neuroscience.

The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.

C. Mantzoros, Sharon H Chou, S. Polyzos, 2014, The Journal of clinical endocrinology and metabolism.

Outliers of bone metabolic diseases.

C. Mantzoros, S. Polyzos, 2017, Metabolism: clinical and experimental.

Hypophosphatasia

S. Polyzos, M. Yavropoulou, S. Tournis, 2021, Journal of clinical medicine.

Nonalcoholic fatty liver disease in males with low testosterone concentrations.

D. Goulis, G. Mintziori, S. Polyzos, 2020, Diabetes & metabolic syndrome.

Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview

S. Polyzos, P. Makras, A. Anastasilakis, 2018, Hormones.

Juvenile Paget disease.

C. Mantzoros, S. Polyzos, T. Cundy, 2017, Metabolism: clinical and experimental.

Impact of Helicobacter pylori and/or Helicobacter pylori–related metabolic syndrome on incidence of all-cause and Alzheimer's dementia

M. Tsolaki, A. Exadaktylos, M. Doulberis, 2019, Alzheimer's & Dementia.

Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones

S. Polyzos, E. Armeni, K. Pafili, 2022, Journal of Endocrinological Investigation.

Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?

E. Dardiotis, J. Kountouras, S. Polyzos, 2017, International journal of cardiology.

Predictors of long-term remission in patients with Graves’ disease: a single center experience

S. Polyzos, S. Katergari, M. Kita, 2013, Endocrine.

Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum.

S. Polyzos, A. Anastasilakis, S. Gerou, 2013, Cytokine.

Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysis

S. Polyzos, A. Goulas, Dimitrios G. Goulis, 2022, Journal of gastroenterology and hepatology.

Helicobacter pylori infection and gastroesophageal reflux disease - Barrett’s esophagus sequence “dilemma”

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, Annals of gastroenterology.

Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)

C. Mantzoros, S. Polyzos, 2020, Metabolism.

Helicobacter pylori infection and the risk for cardiovascular disease.

J. Kountouras, S. Polyzos, P. Katsinelos, 2011, European journal of internal medicine.

Nonalcoholic fatty liver disease and polycystic ovary syndrome.

D. Goulis, J. Kountouras, S. Polyzos, 2015, Annals of hepatology.

Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study

S. Polyzos, A. Slavakis, M. Kita, 2012, Indian journal of endocrinology and metabolism.

Metabolism, clinical and experimental: seventy years young and growing.

C. Mantzoros, G. Matarese, D. Sanoudou, 2022, Metabolism: clinical and experimental.

Novel Advances in the Association Between Helicobacter pylori Infection, Metabolic Syndrome, and Related Morbidity

J. Kountouras, S. Polyzos, 2015, Helicobacter.

Oncogenes' Expression in Greek Patients with Primary Open-Angle Glaucoma in Association with Helicobacter pylori Status

J. Kountouras, S. Polyzos, E. Gavalas, 2012 .

Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases.

J. Kountouras, S. Polyzos, E. Gavalas, 2011, Current molecular medicine.

Helicobacter pylori may play an important role in both axonal type Guillain–Barré syndrome and acute inflammatory demyelinating polyradiculoneuropathy

J. Kountouras, S. Polyzos, E. Vardaka, 2011, Clinical Neurology and Neurosurgery.

Acute transient thyroid swelling following needle biopsy: An update

S. Polyzos, G. Arsos, A. Anastasilakis, 2012, Hormones.

Subendothelial Carotid Hematoma After Fine‐Needle Aspiration Biopsy of a Solitary Thyroid Nodule

S. Polyzos, A. Anastasilakis, P. Nikolopoulos, 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Effects of combined low‐dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non‐invasive indices of steatosis and fibrosis, and adipokine levels in non‐alcoholic fatty liver disease: a randomized controlled trial

C. Mantzoros, J. Kountouras, S. Polyzos, 2017, Diabetes, obesity & metabolism.

Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease

I. Lambrinoudaki, D. Goulis, S. Polyzos, 2022, Hormones.

Adiponectin and vitamin D-binding protein concentrations are independently associated in apparently healthy women but not men: a validation cohort

S. Polyzos, S. Karras, K. Kotsa, 2018, Hormones.

Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis

S. Polyzos, P. Makras, A. Anastasilakis, 2013, Clinical endocrinology.

Obeticholic acid for the treatment of nonalcoholic steatohepatitis: expectations and concerns.

C. Mantzoros, J. Kountouras, S. Polyzos, 2020, Metabolism: clinical and experimental.

Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment

J. Kountouras, S. Polyzos, G. Hawa, 2019, Hormones.

The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.

S. Polyzos, M. Yavropoulou, S. Papapoulos, 2021, The Journal of clinical endocrinology and metabolism.

Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.

C. Mantzoros, S. Polyzos, A. Anastasilakis, 2016, Metabolism: clinical and experimental.

Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.

Maria F. Vasiloglou, S. Polyzos, P. Papaioannidou, 2022, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system.

E. Kazakos, J. Kountouras, S. Polyzos, 2017, Medical hypotheses.

Periostin and sclerostin levels in juvenile Paget's disease.

G. Mintziori, S. Polyzos, E. Terpos, 2017, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

Circulating Periostin Levels do not Differ Between Postmenopausal Women with Normal and Low Bone Mass and are not Affected by Zoledronic Acid Treatment

S. Polyzos, A. Anastasilakis, A. Papatheodorou, 2013, Hormone and Metabolic Research.

Irisin in nonalcoholic fatty liver disease: need for an updated meta-analysis.

J. Kountouras, S. Polyzos, A. Anastasilakis, 2021, Metabolism: clinical and experimental.

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide

S. Polyzos, E. Terpos, A. Anastasilakis, 2011, Osteoporosis International.

Homocysteine in nonalcoholic steatohepatitis: A reply.

J. Kountouras, S. Polyzos, 2016, European journal of internal medicine.

Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications

D. Goulis, S. Polyzos, A. Goulas, 2022, Diabetes, obesity & metabolism.

Denosumab for the treatment of primary pediatric osteoporosis

S. Polyzos, S. Papapoulos, V. Guarnieri, 2021, Osteoporosis International.

The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis.

S. Polyzos, S. Papapoulos, P. Makras, 2020, Bone.

Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.

S. Polyzos, P. Makras, A. Anastasilakis, 2015, Metabolism: clinical and experimental.

Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?

S. Polyzos, M. Yavropoulou, P. Makras, 2018, Calcified Tissue International.

Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.

C. Mantzoros, S. Polyzos, 2017, Metabolism: clinical and experimental.

Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events

P. Vokonas, A. Spiro, C. Mantzoros, 2014, International Journal of Obesity.

The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.

C. Mantzoros, J. Kountouras, S. Polyzos, 2012, Current molecular medicine.

Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial

Z. Sparchez, M. Diculescu, A. Papaefthymiou, 2020, Medicina.

The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease.

J. Kountouras, S. Polyzos, C. Zavos, 2009, Hippokratia.

Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing.

S. Polyzos, A. Goulas, 2020, Medical hypotheses.

Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.

H. Tilg, C. Mantzoros, F. Casanueva, 2020, Metabolism: clinical and experimental.

Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass

S. Polyzos, E. Terpos, M. Yavropoulou, 2019, Journal of musculoskeletal & neuronal interactions.

Serum visfatin in nonalcoholic fatty liver disease.

J. Kountouras, S. Polyzos, I. Romiopoulos, 2014, Annals of hepatology.

The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis.

S. Polyzos, M. Yavropoulou, P. Makras, 2022, Bone.

Impact of Helicobacter pylori on multiple sclerosis‐related clinically isolated syndrome

J. Kountouras, S. Polyzos, P. Katsinelos, 2016, Acta neurologica Scandinavica.

Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer

S. Polyzos, N. Katsiki, 2022, Hormones.

Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis.

J. Kountouras, S. Polyzos, 2020, Annals of hepatology.

Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes‐like approach?

M. Doulberis, J. Kountouras, S. Polyzos, 2018, Hepatology.

CHAI and MACK‐3 as noninvasive indices for nonalcoholic steatohepatitis

J. Kountouras, S. Polyzos, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Helicobacter Pylori and Insulin Resistance Association: Not Just a Myth, Not Yet a Fact

J. Kountouras, S. Polyzos, C. Zavos, 2011, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

Spironolactone Revisited

J. Kountouras, S. Polyzos, C. Zavos, 2011, Journal of clinical hypertension.

Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.

J. Kountouras, S. Polyzos, C. Stergiopoulos, 2010, Medical hypotheses.

Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget’s disease of bone

J. Kountouras, S. Polyzos, G. Arsos, 2010, Osteoporosis International.

Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass.

S. Polyzos, S. Papapoulos, P. Makras, 2012, Bone.

Helicobacter pylori Infection Might Contribute to Esophageal Adenocarcinoma Progress in Subpopulations With Gastroesophageal Reflux Disease and Barrett's Esophagus

J. Kountouras, S. Polyzos, E. Vardaka, 2012, Helicobacter.

Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2022, Arquivos brasileiros de cardiologia.

Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget’s disease

S. Polyzos, E. Terpos, G. Arsos, 2010, Journal of Bone and Mineral Metabolism.

Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatment.

S. Polyzos, Z. Efstathiadou, A. Avramidis, 2008, Endocrine journal.

Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction

J. Kountouras, S. Polyzos, P. Katsinelos, 2011, Journal of Neuroimmunology.

Off-label uses of denosumab in metabolic bone diseases.

S. Polyzos, P. Makras, A. Anastasilakis, 2019, Bone.

Epidemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18 years (1987-2004).

S. Polyzos, A. Benos, N. Flaris, 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Clinical vertebral fractures following denosumab discontinuation

S. Polyzos, E. Terpos, 2016, Endocrine.

Long term follow-up of patients with adrenal incidentalomas--a single center experience and review of the literature.

S. Polyzos, Z. Efstathiadou, M. Kita, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems

J. Kountouras, S. Polyzos, C. Zavos, 2015, Annals of gastroenterology.

Helicobacter pylori-related metabolic syndrome might justify earlier colorectal cancer screening.

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, Gastrointestinal endoscopy.

Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort.

N. Nikolaidis, J. Kountouras, S. Polyzos, 2017, Gastrointestinal endoscopy.

Potential oncogenic properties of mobilized stem cells in a subpopulation of inflammatory bowel disease patients infected with Helicobacter pylori.

J. Kountouras, S. Polyzos, E. Vardaka, 2013, Inflammatory bowel diseases.

Diagnostic approach to Helicobacter pylori-related gastric oncogenesis

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2022, Annals of gastroenterology.

Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1.

S. Polyzos, E. Terpos, G. Arsos, 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Impact of Helicobacter pylori and/or Helicobacter pylori‐related metabolic syndrome on gastroesophageal reflux disease‐ Barrett's esophagus‐ esophageal adenocarcinoma sequence

A. Exadaktylos, M. Doulberis, J. Kountouras, 2018, Helicobacter.

Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?

M. Doulberis, J. Kountouras, S. Polyzos, 2018, Helicobacter.

Helicobacter pylori-Related Impact on Glaucoma Pathophysiology.

J. Kountouras, S. Polyzos, P. Katsinelos, 2015, Investigative ophthalmology & visual science.

Comment on “Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics”

E. Kazakos, J. Kountouras, S. Polyzos, 2017, World Journal of Gastroenterology.

Emerging parameters relevant to the management of antimicrobial‐resistant Helicobacter pylori infection

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2022, Internal medicine journal.

GM‐CSF as a potential candidate of a vaccine‐induced reduction of Helicobacter pylori infection

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2022, Helicobacter.

National consensus on Helicobacter pylori infection: the next-day challenge

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Annals of gastroenterology.

A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders.

E. Kazakos, J. Kountouras, S. Polyzos, 2014, Medical hypotheses.

Pharmacotherapy of type 2 diabetes: An update.

C. Mantzoros, E. Kang, K. Park, 2018, Metabolism: clinical and experimental.

The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2021, Neurochemistry International.

Molecular links between Alzheimer's disease and Gastrointestinal microbiota with its-related metabolic syndrome: emphasis on Helicobacter pylori infection involvement.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, Current molecular medicine.

Thyrotropin receptor autoantibodies and early miscarriages in patients with Hashimoto thyroiditis: a case–control study

D. Goulis, K. Toulis, B. Tarlatzis, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Active Helicobacter pylori infection on colorectal mucosa--adenomatous polyp--adenocarcinoma sequence.

J. Kountouras, S. Polyzos, C. Zavos, 2014, European journal of gastroenterology & hepatology.

Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience

S. Polyzos, Z. Efstathiadou, M. Kita, 2012, Pituitary.

Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

C. Mantzoros, H. Moon, S. Polyzos, 2013, Endocrine reviews.

Letter: low risk of colorectal cancer in a Greek cohort of inflammatory bowel disease patients

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, Alimentary pharmacology & therapeutics.

Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.

C. Mantzoros, S. Polyzos, M. Doumas, 2020, Current vascular pharmacology.

Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.

C. Mantzoros, D. Panagiotakos, C. Chrysohoou, 2022, Clinical nutrition.

Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.

S. Polyzos, P. Fotiadis, D. Molyva, 2013, Metabolism: clinical and experimental.

Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months

C. Mantzoros, S. Polyzos, C. Mantzoros, 2014, Osteoporosis International.

High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density

S. Polyzos, E. Terpos, E. Voskaridou, 2012, Hormone and Metabolic Research.

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.

C. Mantzoros, J. Kountouras, S. Polyzos, 2019, Metabolism: clinical and experimental.

Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge

K. Toulis, S. Polyzos, A. Anastasilakis, 2011, Current opinion in endocrinology, diabetes, and obesity.

Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis.

G. Kaltsas, S. Polyzos, E. Terpos, 2012, The Journal of clinical endocrinology and metabolism.

Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity.

G. Kaltsas, S. Polyzos, E. Terpos, 2017, Metabolism: clinical and experimental.

Acute Liver Failure: From Textbook to Emergency Room and Intensive Care Unit With Concomitant Established and Modern Novel Therapies

A. Exadaktylos, E. Dardiotis, M. Doulberis, 2019, Journal of clinical gastroenterology.

Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population.

S. Polyzos, A. Bargiota, G. Koukoulis, 2016, Hormones.

Clinical complications following thyroid fine‐needle biopsy: a systematic review

S. Polyzos, A. Anastasilakis, 2009, Clinical endocrinology.

Helicobacter pylori on portal hypertension-related hepatic encephalopathy

G. Xiromerisiou, J. Kountouras, S. Polyzos, 2017, Immunopharmacology and immunotoxicology.

Role of autophagy in gastric carcinogenesis

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2021, World journal of gastrointestinal oncology.

Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension

E. Soteriades, A. Papaefthymiou, M. Doulberis, 2021, Microorganisms.

Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.

S. Polyzos, A. Anastasilakis, D. Oikonomou, 2015, Rheumatology.

Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study

C. Mantzoros, J. Chamberland, S. Polyzos, 2016, Leukemia & lymphoma.

Pituitary incidentalomas: a single‐centre experience

S. Polyzos, Z. Efstathiadou, M. Kita, 2011, International journal of clinical practice.

Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesis.

K. Toulis, S. Polyzos, P. Makras, 2011, Medical hypotheses.

Leptin in health and disease: facts and expectations at its twentieth anniversary.

C. Mantzoros, S. Polyzos, 2015, Metabolism: clinical and experimental.

Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget’s disease of bone

S. Polyzos, G. Arsos, Z. Efstathiadou, 2008, Journal of Bone and Mineral Metabolism.

Paget’s Disease of Bone and Calcium Homeostasis: Focus on Bisphosphonate Treatment

S. Polyzos, A. Anastasilakis, E. Terpos, 2011, Experimental and Clinical Endocrinology & Diabetes (Barth).

Pharmacotherapy of obesity: Available medications and drugs under investigation.

C. Mantzoros, S. Polyzos, O. Farr, 2019, Metabolism: clinical and experimental.

Paget’s disease of bone: emphasis on treatment with zoledronic acid

S. Polyzos, E. Terpos, A. Anastasilakis, 2009, Expert review of endocrinology & metabolism.

Micro-Ultrasound–Guided vs Multiparametric Magnetic Resonance Imaging-Targeted Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis

A. Papatsoris, S. Polyzos, A. Anastasiadis, 2021, The Journal of urology.

Adiponectin and Pathogenesis of NAFLD The Multi-hit Hypothesis and the Role of Insulin Resistance and Adipose Tissue

J. Kountouras, S. Polyzos, C. Zavos, 2010 .

Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man.

S. Polyzos, A. Anastasilakis, I. Iakovou, 2010, Arquivos brasileiros de endocrinologia e metabologia.

Long‐term effects of thyroid fine‐needle biopsy on the thyroid‐related biochemical parameters

K. Toulis, M. Alevizaki, S. Polyzos, 2012, International journal of clinical practice.

Non-Functioning Pituitary Adenomas: A Single Center Experience

S. Polyzos, Z. Efstathiadou, M. Kita, 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.

S. Polyzos, A. Goulas, E. Makri, 2020, Archives of medical research.

Oxidative Stress and Reduced Antioxidative Status, along with Endothelial Dysfunction in Acromegaly

S. Polyzos, Z. Efstathiadou, M. Kita, 2012, Hormone and Metabolic Research.

Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2022, Digestive Diseases and Sciences.

Potential molecular aspects of Helicobacter pylori-related hyperplastic polyp development and progression.

J. Kountouras, S. Polyzos, P. Katsinelos, 2016, European journal of gastroenterology & hepatology.

Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.

C. Mantzoros, E. Kazakos, M. Doulberis, 2018, Metabolism: clinical and experimental.

RANKL inhibition for the management of patients with benign metabolic bone disorders

K. Toulis, S. Polyzos, E. Terpos, 2009, Expert opinion on investigational drugs.

RANKLinhibitionforthe managementofpatientswith benignmetabolicbonedisorders

K. Toulis, S. Polyzos, E. Terpos, 2009 .

The Association Between Helicobacter pylori Infection and Insulin Resistance: A Systematic Review

Jannis Kountouras, J. Kountouras, S. Polyzos, 2011, Helicobacter.

Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives.

S. Polyzos, V. Venetsanaki, 2019, Current vascular pharmacology.

Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis

S. Polyzos, P. Makras, A. Anastasilakis, 2015, Expert opinion on investigational drugs.

Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients

A. Exadaktylos, A. Papaefthymiou, M. Doulberis, 2021, Microorganisms.

Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2023, Medicina.

Impact of nonalcoholic fatty liver disease-related metabolic state on depression

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2023, Neurochemistry International.

The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, Journal of neurogastroenterology and motility.

Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine

M. Doulberis, J. Kountouras, S. Polyzos, 2019, Annals of gastroenterology.

Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece

J. Kountouras, S. Polyzos, N. Grigoriadis, 2010, Multiple sclerosis.

Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis

J. Kountouras, S. Polyzos, P. Katsinelos, 2013, Hepatology.

Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients

A. Exadaktylos, A. Papaefthymiou, M. Doulberis, 2020, Journal of clinical medicine.

Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.

E. Dardiotis, J. Kountouras, S. Polyzos, 2017, International journal of cardiology.

Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2022, Metabolism: Clinical and Experimental.

Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2021, Journal of neurogastroenterology and motility.

Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease

M. Doulberis, J. Kountouras, S. Polyzos, 2019, Annals of gastroenterology.

Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Letter: Helicobacter pylori in lean and obese patients with non‐alcoholic fatty liver disease

M. Doulberis, J. Kountouras, S. Polyzos, 2017, Alimentary pharmacology & therapeutics.

A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke.

J. Kountouras, S. Polyzos, P. Katsinelos, 2017, Sleep Medicine.

Helicobacter pylori‐related chronic hepatitis C infection and the risk for cardiovascular disease

J. Kountouras, S. Polyzos, P. Katsinelos, 2017, Liver international (Print).

Extragastric Diseases and Helicobacter pylori

Antonio Gasbarrini, Francesco Franceschi, Jannis Kountouras, 2013, Helicobacter.

Helicobacter pylori might contribute to nonalcoholic fatty liver disease–related cardiovascular events by releasing prothrombotic and proinflammatory factors

Jannis Kountouras, J. Kountouras, S. Polyzos, 2014, Hepatology.

Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.

J. Kountouras, S. Polyzos, C. Zavos, 2012, Journal of clinical gastroenterology.

Helicobacter pylori Associated With Obstructive Sleep Apnea Might Contribute to Sleep, Cognition, and Driving Performance Disturbances in Patients With Cirrhosis.

J. Kountouras, S. Polyzos, G. Deretzi, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Helicobacter pylori may play a role in both obstructive sleep apnea and metabolic syndrome.

J. Kountouras, S. Polyzos, P. Katsinelos, 2012, Sleep medicine.

Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2021, Metabolism: clinical and experimental.

Impact of Helicobacter pylori‐linked metabolic syndrome on non‐alcoholic fatty liver disease and its connected atrial fibrillation risk

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Liver international : official journal of the International Association for the Study of the Liver.

A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection

E. Dardiotis, A. Papaefthymiou, M. Doulberis, 2019, Annals of the New York Academy of Sciences.

Helicobacter pylori infection as a potential risk factor for multiple sclerosis.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Medical hypotheses.

Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology

M. Doulberis, J. Kountouras, S. Polyzos, 2018, Digestive Diseases and Sciences.

Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?

C. Mantzoros, S. Polyzos, C. Boutari, 2019, Metabolism: clinical and experimental.

Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease

C. Mantzoros, S. Polyzos, Dimitrios D Raptis, 2023, Therapeutics and clinical risk management.

Transient Sigmoidorectal Intussusception Simulating Submucosal Tumor in a Healthy Woman: An Unusual Case and Review of the Literature

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020 .

Correction to: A mutation in NOTCH2 gene first associated with Hajdu–Cheney syndrome in a Greek family: diversity in phenotype and response to treatment

S. Polyzos, I. Georgiou, Z. Efstathiadou, 2020, Endocrine.

A mutation in NOTCH2 gene first associated with Hajdu–Cheney syndrome in a Greek family: diversity in phenotype and response to treatment

S. Polyzos, I. Georgiou, Z. Efstathiadou, 2020, Endocrine.

Cilofexor for the treatment of nonalcoholic steatohepatitis.

J. Kountouras, S. Polyzos, Konstantinos Xanthopulos, 2021, Current Vascular Pharmacology.

Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori–related nitrosative stress

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Annals of the New York Academy of Sciences.

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non‐diabetic patients with dyslipidaemia: a prospective randomised open‐label study

D. Mikhailidis, S. Polyzos, A. Karagiannis, 2011, International journal of clinical practice.

Adult hypophosphatasia treated with reduced frequency of teriparatide dosing

S. Polyzos, P. Kollia, M. Whyte, 2021, Journal of musculoskeletal & neuronal interactions.

Nonalcoholic fatty liver disease and hepatocellular carcinoma: insights in epidemiology, pathogenesis, imaging, prevention and therapy.

E. Cholongitas, S. Polyzos, Lampros Chrysavgis, 2023, Seminars in cancer biology.

Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis

S. Polyzos, M. Georgiadou, A. Apostolopoulos, 2021, Journal of gastroenterology and hepatology.

Non-alcoholic fatty liver disease in children.

S. Polyzos, D. Mikhailidis, C. Mantzoros, 2022, Current vascular pharmacology.

The effect of teriparatide on serum Dickkopf‐1 levels in postmenopausal women with established osteoporosis

K. Toulis, S. Polyzos, E. Terpos, 2009, Clinical endocrinology.

Innate immunity and nonalcoholic fatty liver disease

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2023, Annals of gastroenterology.

Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls

C. Mantzoros, S. Polyzos, A. Anastasilakis, 2018, Hormone and Metabolic Research.

Efficacy and Safety of Denosumab in Postmenopausal Women with Osteopenia or Osteoporosis: A Systematic Review and a Meta-analysis

D. Goulis, K. Toulis, S. Polyzos, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Potential implications of Helicobacter pylori-related neutrophil-activating protein.

J. Kountouras, S. Polyzos, P. Katsinelos, 2012, World journal of gastroenterology.

Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene).

D. Naot, S. Polyzos, A. Anastasilakis, 2014, The Journal of clinical endocrinology and metabolism.

Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives.

C. Mantzoros, Sharon H Chou, S. Polyzos, 2013, Cell metabolism.

Head‐to‐head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial

S. Polyzos, A. Anastasilakis, Z. Efstathiadou, 2008, International journal of clinical practice.

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

K. Toulis, S. Polyzos, P. Makras, 2012, Therapeutics and clinical risk management.

Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐Year Clinical Trial

S. Polyzos, S. Papapoulos, P. Makras, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?

J. Kountouras, S. Polyzos, E. Gavalas, 2011, Experimental eye research.

Adipokines in nonalcoholic fatty liver disease.

C. Mantzoros, J. Kountouras, S. Polyzos, 2016, Metabolism: clinical and experimental.

S. Polyzos, S. Karras, K. Kotsa, 2020, International journal of food sciences and nutrition.

Helicobacter pylori infection as a risk factor for both primary open-angle glaucoma and pseudoexfoliative glaucoma in Thessaloniki Eye Study.

J. Kountouras, S. Polyzos, C. Zavos, 2011, American journal of ophthalmology-glaucoma.

Comments to the Editor concerning the paper entitled “The microbiome and ophthalmic disease” by Baim et al.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, Experimental biology and medicine.

Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease.

Jannis Kountouras, J. Kountouras, S. Polyzos, 2014, Medical hypotheses.

Helicobacter pylori infection and Parkinson’s disease: apoptosis as an underlying common contributor

J. Kountouras, S. Polyzos, P. Katsinelos, 2012, European journal of neurology.

An association study of the PNPLA3 I148M polymorphism (rs738409) with serum lipids in patients with dyslipidemia

S. Polyzos, A. Goulas, G. Germanidis, 2023, Exploration of Medicine.

Association between Active Helicobacter pylori Infection and Glaucoma: A Systematic Review and Meta-Analysis

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Microorganisms.

Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, Cellular and Molecular Life Sciences.

Vitamin D Deficiency and Unclear Abdominal Pain in Patients from Low- and Middle-Income Countries

A. Exadaktylos, A. Papaefthymiou, M. Doulberis, 2019, International journal of environmental research and public health.

Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2021, Journal of Crohn's & Colitis.

Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study

C. Mantzoros, E. Papakonstantinou, S. Polyzos, 2018, The Journal of clinical endocrinology and metabolism.

Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.

C. Mantzoros, J. Kountouras, S. Polyzos, 2017, Metabolism: clinical and experimental.

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women — The six-month effect of risedronate and teriparatide

S. Polyzos, E. Terpos, A. Anastasilakis, 2011 .

Obesity: seize the day, fight the fat.

C. Mantzoros, S. Polyzos, 2019, Metabolism: clinical and experimental.

Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study.

C. Mantzoros, S. Polyzos, B. Kalra, 2022, Metabolism: clinical and experimental.

Multiple sclerosis and seizures: possible role of Helicobacter pylori

J. Kountouras, S. Polyzos, P. Katsinelos, 2011, European journal of neurology.

Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis.

J. Kountouras, S. Polyzos, P. Katsinelos, 2011, Joint, bone, spine : revue du rhumatisme.

Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case–control study

C. Mantzoros, S. Polyzos, B. Kalra, 2023, Endocrine.

Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment

S. Polyzos, A. Anastasilakis, A. Papatheodorou, 2013, Osteoporosis International.

Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease: Is There a Relation?

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Obesity Surgery.

Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2022, Journal of gastrointestinal cancer.

Letter to the Editor Regarding “The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy” by Abeid et al.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2022, Obesity Surgery.

Active Helicobacter pylori Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence

J. Kountouras, S. Polyzos, P. Katsinelos, 2017, Gut and liver.

Active Helicobacter pylori infection is associated with colorectal mucosa – adenomatous polyp – early and advanced adenocarcinoma sequence

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, Scandinavian journal of gastroenterology.

Helicobacter pylori might contribute to cancer and/or bone marrow-derived stem cell-related gastrointestinal oncogenesis

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, Oncogene.

Helicobacter pylori and Colorectal Cancer Risk—Letter

J. Kountouras, S. Polyzos, P. Katsinelos, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Letter: is Helicobacter pylori behind Barrett's oesophagus and colorectal neoplasms?

J. Kountouras, S. Polyzos, P. Katsinelos, 2013, Alimentary pharmacology & therapeutics.

Helicobacter pylori Infection and Insulin Resistance

J. Kountouras, S. Polyzos, C. Zavos, 2013, Helicobacter.

Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study

C. Mantzoros, J. Chamberland, S. Polyzos, 2014, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Helicobacter pylori infection and diabetes mellitus.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2021, Diabetes & metabolic syndrome.

Influence of Helicobacter pylori‐connected metabolic syndrome on non‐alcoholic fatty liver disease and its related colorectal neoplasm high risk

A. Papaefthymiou, J. Kountouras, S. Polyzos, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Letter: Helicobacter pylori in proton pump inhibitor‐associated biliary disease

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2020, Alimentary Pharmacology and Therapeutics.

Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?

C. Mantzoros, J. Kountouras, S. Polyzos, 2019, Metabolism: clinical and experimental.

Helicobacter pylori infection and oesophageal adenocarcinoma.

J. Kountouras, S. Polyzos, P. Katsinelos, 2016, Cancer Epidemiology.

Association between cirrhosis and Helicobacter pylori-related brain pathologies.

J. Kountouras, S. Polyzos, P. Katsinelos, 2015, European Journal of Gastroenterology and Hepathology.

Helicobacter pylori's potential association with epilepsy

J. Kountouras, S. Polyzos, P. Katsinelos, 2012, Seizure.

Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion

S. Polyzos, M. Yavropoulou, P. Makras, 2021, Endocrine.

Serum sclerostin levels following treatment with parathyroid hormone

S. Polyzos, A. Anastasilakis, E. Terpos, 2013, Journal of Endocrinological Investigation.

The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration.

E. Kazakos, M. Doulberis, J. Kountouras, 2017, Current molecular medicine.

Comment on "The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia".

J. Kountouras, S. Polyzos, P. Katsinelos, 2016, European review for medical and pharmacological sciences.

Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration

J. Kountouras, S. Polyzos, C. Zavos, 2016, Annals of gastroenterology.

Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation

S. Polyzos, M. Yavropoulou, P. Makras, 2021, Calcified Tissue International.

The intriguing connections of leptin to hyperparathyroidism

L. Duntas, S. Polyzos, J. Bollerslev, 2017, Endocrine.

Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

S. Polyzos, Ilias D Vachliotis, Ilias D. Vachliotis, 2023, Current Obesity Reports.

Association between Helicobacter pylori Infection and Nasal Polyps: A Systematic Review and Meta-Analysis

E. Kazakos, G. Rogler, A. Papaefthymiou, 2023, Microorganisms.

Helicobacter Pylori-Related Vitamin B12 Deficiency: A Potential Contributor in Neuropsychiatric Disorders

J. Kountouras, S. Polyzos, N. Grigoriadis, 2015, Indian journal of psychological medicine.

Letter: apoptosis and hepatic fibrosis in chronic hepatitis B

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, Alimentary pharmacology & therapeutics.

Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation.

S. Polyzos, M. Yavropoulou, P. Makras, 2021, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease.

C. Mantzoros, S. Polyzos, 2014, Metabolism: clinical and experimental.

Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

I. Lambrinoudaki, D. Goulis, N. Georgopoulos, 2019, Endocrine.

The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease

S. Polyzos, Ilias D Vachliotis, 2023, Current Obesity Reports.

Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?

S. Polyzos, M. Yavropoulou, P. Makras, 2018, Calcified Tissue International.

Serum Osteoprotegerin and RANKL are not Specifically Altered in Women with Postmenopausal Osteoporosis Treated with Teriparatide or Risedronate: A Randomized, Controlled Trial

S. Polyzos, A. Anastasilakis, A. Avramidis, 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital.

A. Maniatis, S. Polyzos, S. Pournaras, 2003, Journal of Antimicrobial Chemotherapy.

The use of demographic, ultrasonographic and scintigraphic data in the diagnostic approach of thyroid nodules.

S. Polyzos, Z. Efstathiadou, A. Benos, 2008, Experimental and clinical endocrinology & diabetes.

Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing

S. Polyzos, A. Goulas, 2020, Medical Hypotheses.

Effect of Strontium Ranelate on Lumbar Spine Bone Mineral Density in Women with Established Osteoporosis Previously Treated with Teriparatide

S. Polyzos, A. Anastasilakis, A. Avramidis, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis

D. Goulis, G. Mintziori, J. Kountouras, 2002, Hormones.

Potential Impact of Helicobacter pylori Infection On Reflux Disease Sequence: Illuminating the Gap.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2019, Journal of Clinical Gastroenterology.

Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited.

A. Papaefthymiou, M. Doulberis, J. Kountouras, 2020, Journal of gastrointestinal and liver diseases : JGLD.

Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

S. Polyzos, A. Goulas, A. Mataftsi, 2023, Journal of personalized medicine.

Micro-ultrasound-guided versus multiparametric magnetic resonance imaging-targeted biopsy in the detection of prostate cancer: a systematic review and meta-analysis

S. Polyzos, P. Sountoulides, Eirini Asouhidou, 2021 .

Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.

C. Mantzoros, S. Polyzos, Ilias D Vachliotis, 2023, Metabolism: clinical and experimental.

Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease

C. Mantzoros, J. Kountouras, S. Polyzos, 2015, Endocrine.

Juvenile Paget disease.

C. Mantzoros, S. Polyzos, T. Cundy, 2017, Metabolism: clinical and experimental.

Relationship between Helicobacter pylori infection and autoimmune disorders

J. Kountouras, S. Polyzos, P. Katsinelos, 2013, Clinical chemistry and laboratory medicine.

Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive non-alcoholic fatty liver disease indexes: Results from a large multi-center study.

C. Mantzoros, G. Markakis, S. Polyzos, 2023, Metabolism: clinical and experimental.

THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.

S. Polyzos, P. Makras, A. Anastasilakis, 2018, European journal of endocrinology.

Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation.

J. Kountouras, S. Polyzos, P. Katsinelos, 2016, Medical hypotheses.

Pituitary metastasis as a presenting manifestation of silent systemic malignancy: A retrospective analysis of four cases

S. Polyzos, A. Slavakis, M. Kita, 2012, Indian journal of endocrinology and metabolism.

Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology.

J. Kountouras, S. Polyzos, 2019, Journal of clinical gastroenterology.

Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.

E. Kazakos, A. Papaefthymiou, M. Doulberis, 2023, Clinical immunology.

Association between Helicobacter pylori burden and Alzheimer's disease

J. Kountouras, S. Polyzos, P. Katsinelos, 2014, European journal of neurology.

Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives.

C. Mantzoros, Sharon H Chou, S. Polyzos, 2013, Cell metabolism.

Serum homocysteine levels in patients with nonalcoholic fatty liver disease.

J. Kountouras, S. Polyzos, P. Katsinelos, 2011, Annals of hepatology.

Nonalcoholic fatty future disease.

C. Mantzoros, S. Polyzos, 2016, Metabolism: clinical and experimental.

Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead.

C. Mantzoros, S. Polyzos, 2018, Metabolism: clinical and experimental.

The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.

C. Mantzoros, Sharon H Chou, S. Polyzos, 2014, The Journal of clinical endocrinology and metabolism.

Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates

C. Annweiler, D. Naughton, C. Wagner, 2017, Endocrine.

S. Polyzos, P. Makras, A. Anastasilakis, 2023, Journal of clinical medicine.

Circulating homocysteine in nonalcoholic fatty liver disease.

J. Kountouras, S. Polyzos, M. Tsoukas, 2015, European journal of internal medicine.

Commentary: are blood and saliva sources of COVID-19 spread?

M. Doulberis, S. Polyzos, E. Vardaka, 2021, European review for medical and pharmacological sciences.

Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.

S. Polyzos, P. Makras, A. Anastasilakis, 2015, Metabolism: clinical and experimental.